Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -5 of 5
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
5/1/1990
1.
Phase III Placebo-Controlled Randomized Study of IGIV pH 4.25 in the Prophylaxis of Infections in Patients with Chronic Lymphocytic Leukemia and Multiple Myeloma Who Have Experienced Recurrent Infections (Summary Last Modified 05/90)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Closed
18 and over
CBM-532-8705
NCI-V88-0583
Last Modified:
8/10/2006
2.
Phase II Study of Unrelated Bone Marrow Transplantation with Cyclophosphamide and Total-Body Irradiation in Patients With Hematologic Malignancies/Disorders
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
17 to 60
Other
TUHSC-2803
NCI-V96-0950, NCT00002809
Last Modified:
5/3/2007
3.
Phase II Pilot Feasibility Study of High-Dose Chemotherapy with CTX/VP-16 or CTX/ARA-C/AZQ, Total-Body Irradiation, and HLA-Mismatched Bone Marrow Transplantation in the Treatment of Aggressive Malignancy
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
over 5
NCI
NCI-86-C-12A
NCI-T86-0057N, T86-0057
Last Modified:
3/1/1988
4.
Phase II Study of Prophylactic Immunoglobulin in Patients Undergoing Autologous or Allogeneic Bone Marrow Transplantation
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Supportive care, Treatment
Closed
1 to 60
GUMC-BMT-8
NCI-V87-0320
Last Modified:
2/1/1990
5.
Pilot Study of High-Dose Continuous Infusional Intravenous Immunoglobulin in Patients Undergoing Bone Marrow Transplantation
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Supportive care, Treatment
Closed
any age
GUMC-12089
NCI-V89-0237
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute